Cara Therapeutics
CARA
#10362
Rank
ยฃ5.95 M
Marketcap
ยฃ3.90
Share price
-2.56%
Change (1 day)
-0.80%
Change (1 year)

EPS for Cara Therapeutics (CARA)

EPS in 2024 (TTM): -ยฃ16.45

According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ15.41. In 2023 the company made an earnings per share (EPS) of -ยฃ19.19 a decrease over its 2022 EPS that were of -ยฃ14.00.

EPS history for Cara Therapeutics from 2013 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-ยฃ16.45-14.31%
2023-ยฃ19.1937.11%
2022-ยฃ14.00-8.09%
2021-ยฃ15.23
2019-ยฃ21.9220.87%
2018-ยฃ18.147.85%
2017-ยฃ16.82-9.05%
2016-ยฃ18.49110%
2015-ยฃ8.8017.65%
2014-ยฃ7.48-3.42%
2013-ยฃ7.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ7.66-149.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.26-108.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-ยฃ25.49 65.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ36.91 139.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-ยฃ1.64-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA